Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Current Taxes (2018 - 2025)

Protagonist Therapeutics' Current Taxes history spans 3 years, with the latest figure at $1.9 million for Q1 2025.

  • For Q1 2025, Current Taxes fell 43.21% year-over-year to $1.9 million; the TTM value through Mar 2025 reached $1.9 million, down 43.21%, while the annual FY2024 figure was $2.7 million, N/A changed from the prior year.
  • Current Taxes for Q1 2025 was $1.9 million at Protagonist Therapeutics, down from $2.7 million in the prior quarter.
  • Across five years, Current Taxes topped out at $3.3 million in Q1 2024 and bottomed at $1.0 million in Q3 2024.